Hyperparathyroidism secondary – Life with Disease

Go back

Secondary hyperparathyroidism is a health condition where the parathyroid glands in the neck work too hard, producing excess amounts of a hormone that affects calcium and bone health, most commonly in people with chronic kidney disease or vitamin D deficiency.

Understanding the Outlook for Secondary Hyperparathyroidism

The outlook for people living with secondary hyperparathyroidism depends greatly on what is causing the condition and how early it is identified and managed. This is a condition that requires ongoing attention, and understanding what lies ahead can help patients and their families prepare for the journey[4].

When secondary hyperparathyroidism develops due to chronic kidney disease (a long-term condition where the kidneys gradually lose their ability to work properly), the prognosis is closely tied to the stage and progression of the kidney disease itself. Around 15% of people in the United States have some form of chronic kidney disease, and as kidney function declines through the different stages, the prevalence of secondary hyperparathyroidism increases. The condition becomes more common and more severe in advanced kidney disease[4].

For patients who can address the underlying cause successfully, the outlook can be quite positive. For example, individuals whose secondary hyperparathyroidism stems from vitamin D deficiency may see significant improvement simply by restoring their vitamin D levels to a healthy range. About half of the world’s population experiences vitamin D insufficiency, making this a common but treatable cause[4].

When the underlying problem is kidney failure, the most definitive solution is a kidney transplant. Many people who receive a successful kidney transplant see improvement in their secondary hyperparathyroidism. However, it’s important to understand that the condition may not completely resolve even after transplantation. Some individuals continue to experience a degree of persistent hyperparathyroidism, which doctors sometimes call tertiary hyperparathyroidism, even after their new kidney is functioning[4][5].

⚠️ Important
Long-term secondary hyperparathyroidism is associated with serious health problems affecting the heart and blood vessels. The condition causes disturbances in how the body handles calcium and phosphorus, leading to calcium deposits forming in blood vessels and heart tissue, which contributes to cardiovascular illness and early death in people on dialysis. This makes early recognition and treatment essential for better long-term outcomes.

Medical treatment can help control the condition in many patients, but unfortunately, it doesn’t work for everyone. Studies show that up to 25% of people with kidney failure and secondary hyperparathyroidism do not respond adequately to medications. For these individuals, surgery may become necessary. However, even surgical treatment doesn’t fix the underlying kidney problem, so there remains a high risk that the secondary hyperparathyroidism will return over time[5].

If secondary hyperparathyroidism goes untreated for a prolonged period, the parathyroid glands can become so enlarged and overactive that they stop responding to the body’s normal control signals. This progression to what doctors call tertiary hyperparathyroidism represents a more challenging situation where correcting the original problem no longer stops the excessive hormone production. The glands have essentially become autonomous, continuing to produce too much parathyroid hormone (a chemical messenger that controls calcium levels in the blood) regardless of what the body needs[6][7].

How the Disease Develops Without Treatment

Understanding the natural progression of secondary hyperparathyroidism helps explain why early intervention matters so much. The condition doesn’t appear overnight but develops gradually as the body tries to compensate for imbalances in calcium, phosphorus, and vitamin D[4].

In people with declining kidney function, the kidneys lose their ability to perform two critical tasks: converting vitamin D into its active form that the body can use, and removing excess phosphorus through urine. When the kidneys can’t make active vitamin D anymore, the intestines can’t absorb calcium properly from food. At the same time, phosphorus starts building up in the bloodstream because the kidneys can’t filter it out effectively. Both of these changes lead to low calcium levels in the blood, a condition called hypocalcemia[4][5].

The parathyroid glands, which are four small glands about the size of a grain of rice located behind the thyroid in the neck, sense this low calcium. In response, they start producing more parathyroid hormone to try to bring calcium levels back up. The hormone works by telling the bones to release calcium, the kidneys to hold onto calcium rather than losing it in urine, and (through vitamin D) the intestines to absorb more calcium from food. This is actually a protective response in the beginning[6].

However, when the underlying kidney problem persists, the parathyroid glands face constant stimulation to produce more hormone. Over time, this relentless demand causes the glands themselves to grow larger, a process called hyperplasia (enlargement of an organ or tissue caused by an increase in the number of its cells). The enlarged glands produce even more parathyroid hormone, creating a cycle that intensifies the problem[4].

As months and years pass without treatment, the continuously elevated parathyroid hormone takes an increasing toll on the skeleton. The hormone keeps instructing bones to release calcium, which weakens the bone structure. Bones become thin and brittle, losing their strength and density. Meanwhile, all that extra calcium being pulled from the bones has to go somewhere. It begins depositing in places where it doesn’t belong—in blood vessels, heart tissue, joints, and soft tissues throughout the body[4][5].

The progression from secondary to tertiary hyperparathyroidism represents a point of no return in the disease course. Once the parathyroid glands have been stimulated for so long that they undergo irreversible changes, they lose their ability to respond to the body’s normal feedback signals. Even if kidney function could be restored at this point, the glands would continue overproducing hormone independently. At this stage, calcium levels may actually become elevated rather than low, compounding the problems with unwanted calcium deposits[6][7].

Potential Complications That May Arise

Secondary hyperparathyroidism can lead to a range of serious complications that extend far beyond the parathyroid glands themselves. These complications can significantly impact quality of life and overall health, which is why medical teams work hard to prevent them through early treatment[4].

Bone complications are among the most direct consequences of untreated secondary hyperparathyroidism. The constant removal of calcium from bones to maintain blood calcium levels leads to weakened bone structure, a condition that doctors describe as disturbances in bone turnover. People may develop bone pain that can be severe and persistent. Bones become more likely to break with minimal trauma, and in growing children, bone deformities may develop as the skeleton fails to form properly. Joint pain is also common as the disease affects the entire skeletal system[6][7].

Perhaps the most dangerous complications involve the cardiovascular system. The combination of high phosphorus levels and elevated parathyroid hormone causes calcium to deposit in blood vessels and heart tissue, a process called vascular calcification (hardening of blood vessels due to calcium buildup). These calcium deposits make blood vessels stiff and less able to expand and contract properly, contributing to high blood pressure and increasing the risk of heart attacks and strokes. This cardiovascular impact is a major reason why secondary hyperparathyroidism is associated with increased illness and death rates, particularly in people on dialysis[4].

A particularly severe and frightening complication is calciphylaxis, a rare but serious condition where calcium deposits form in the skin and muscles. This causes extremely painful skin lesions that look purple or mottled. Over time, these lesions can progress to tissue death, creating open ulcers that are difficult to heal and prone to severe infections. Calciphylaxis is considered a medical emergency and requires immediate treatment[5].

The disease also has widespread effects throughout the body that medical sources describe as pleiotropic (affecting multiple different systems or producing multiple different effects). The blood system, immune system, and nervous system can all be affected. People may experience problems with their immune response, making them more vulnerable to infections. Neurological symptoms can include difficulty concentrating, memory problems, confusion, and changes in mental function[6][7].

When parathyroid hormone levels become extremely elevated—sometimes reaching levels in the hundreds or even thousands in people with kidney failure—patients may develop severe, uncontrollable itching called pruritus. This symptom can be so distressing that it significantly affects daily life and sleep, and it may become one of the indicators that surgery is needed[5].

⚠️ Important
The complications of secondary hyperparathyroidism don’t just affect physical health. The combination of bone pain, severe itching, fatigue, and other symptoms can lead to depression and significantly reduced quality of life. The psychological impact of living with these chronic symptoms should not be underestimated, and mental health support is an important part of comprehensive care.

For people on dialysis, the inability to properly control calcium and phosphorus levels despite the dialysis treatments represents another serious complication. When secondary hyperparathyroidism is severe, even regular dialysis sessions may not be enough to maintain safe mineral balance in the blood. This situation can become one of the reasons why surgery is eventually recommended[5].

Impact on Daily Life and Activities

Living with secondary hyperparathyroidism affects many aspects of daily life, from physical capabilities to emotional wellbeing and social interactions. Understanding these impacts helps patients and families prepare for the challenges and find ways to cope[6].

Physical symptoms can be quite limiting. Bone and joint pain are common complaints that can make it difficult to perform routine activities like walking, climbing stairs, or carrying groceries. Muscle weakness adds to these challenges, making even simple tasks feel exhausting. People often describe a persistent tiredness or fatigue (a feeling of exhaustion that doesn’t improve with rest) that isn’t relieved by sleep, making it hard to maintain energy throughout the day[6].

For those experiencing severe pruritus, the constant itching can be maddening. It often worsens at night, disrupting sleep and leaving people exhausted during the day. The inability to find relief from itching can affect concentration at work or school and make it difficult to relax or enjoy leisure activities. Some people find themselves avoiding social situations because they’re embarrassed by their need to scratch constantly[5].

Work life can be particularly challenging. People with secondary hyperparathyroidism often need to take time off for medical appointments, dialysis treatments (if applicable), and managing complications. The fatigue and difficulty concentrating can reduce productivity and make it hard to meet job demands. Some individuals find they need to reduce their working hours or even leave employment, which brings financial stress in addition to the emotional impact of losing professional identity and purpose[6].

The psychological and emotional effects are substantial. Depression is a recognized symptom of hyperparathyroidism, likely related to both the direct effects of elevated parathyroid hormone on the brain and the stress of living with chronic illness. People may struggle with memory problems, difficulty concentrating, and feelings of confusion or mental fog. These cognitive symptoms can be frustrating and frightening, making people worry about their mental capabilities[6].

Diet requires constant vigilance for people with secondary hyperparathyroidism, particularly those with kidney disease. Managing phosphorus intake means carefully reading food labels and avoiding many common foods that are naturally high in phosphorus or that have phosphorus-containing additives. This dietary restriction can make social eating difficult—going to restaurants or attending dinner parties requires planning and sometimes uncomfortable explanations about dietary needs. For many cultures where food is central to social connection and celebration, these restrictions can feel isolating[5].

Physical activity and hobbies may need modification. Weakened bones increase the risk of fractures, so high-impact activities or contact sports may no longer be safe. People who previously enjoyed active hobbies like hiking, dancing, or playing sports may need to find gentler alternatives. This loss of beloved activities can contribute to feelings of grief for the life they had before illness[7].

Family relationships also feel the strain. Partners may need to take on additional household responsibilities, and role reversals can create stress and resentment. Parents with secondary hyperparathyroidism worry about their ability to care for their children. The emotional burden on family members who watch their loved one struggle with pain and fatigue shouldn’t be overlooked. Communication within families can become strained when the person with illness tries to maintain normalcy or hide symptoms to avoid burdening others[6].

However, many people develop effective coping strategies over time. Building a routine around medical treatments helps create a sense of control. Connecting with others who have similar conditions through support groups provides validation and practical advice. Working with healthcare teams to manage symptoms as effectively as possible improves daily function. Pacing activities and learning to recognize limits helps prevent exhaustion. Some people find that occupational therapy helps them discover adaptive strategies for daily tasks[6].

Finding joy and meaning despite illness becomes important. Many people speak about appreciating small pleasures more, strengthening relationships that matter most, and discovering inner resilience they didn’t know they had. While secondary hyperparathyroidism undeniably changes life, it doesn’t have to define it completely. With support, adaptation, and effective medical management, many people maintain good quality of life[6].

Supporting Family Members: Clinical Trials and Care

Families play a crucial role in supporting someone with secondary hyperparathyroidism, particularly when it comes to exploring treatment options like clinical trials. Understanding what clinical trials are and how they work can help families guide their loved one through the decision-making process about participation[1].

Clinical trials are research studies that test whether new medical approaches are safe and effective. In the context of secondary hyperparathyroidism, trials might test new medications to control parathyroid hormone levels, investigate different surgical techniques, or explore novel approaches to managing complications. These studies follow strict protocols and are carefully designed to protect participant safety while advancing medical knowledge[1].

Family members should understand that participating in a clinical trial is completely voluntary. The decision to join a trial should be made carefully after discussing with the medical team and understanding both potential benefits and risks. Trials offer the opportunity to access cutting-edge treatments before they’re widely available, and participants often receive extra monitoring and attention from medical teams. However, new treatments may have unknown side effects, and there’s no guarantee that an experimental treatment will work better than standard care[1].

When helping a loved one consider a clinical trial, families can assist in several practical ways. First, they can help gather information by accompanying their loved one to appointments where trials are discussed, taking notes, and asking clarifying questions. Having another set of ears in the room helps ensure important details aren’t missed. Families can help research the trial online, looking for information about the investigators, the institution, and what other patients have said about their experiences[1].

Understanding the informed consent process is important for families. Before joining any clinical trial, participants must sign an informed consent document that explains what the study involves, what will be asked of them, what the potential risks and benefits are, and what alternatives exist. Family members can help by reading through this document with their loved one, ensuring all questions are answered, and supporting them in making a decision that feels right[1].

Practical support becomes essential if a loved one joins a trial. Clinical trials often require more frequent visits to the medical center than standard care. Family members can help with transportation to appointments, arranging time off work if needed, and managing household responsibilities so the person can focus on their health. Keeping track of appointment schedules, medication changes, and any symptoms or side effects to report helps ensure the trial goes smoothly[1].

Families should know that participants can leave a clinical trial at any time, for any reason, without affecting their regular medical care. If your loved one becomes uncomfortable with the trial, experiences concerning side effects, or simply changes their mind, they have the absolute right to withdraw. Supporting this decision, whatever it is, helps maintain trust and ensures the person feels in control of their healthcare[1].

Beyond clinical trials, families can support their loved one in many other ways. Learning about secondary hyperparathyroidism helps families understand what their loved one is experiencing and what to watch for. Accompanying them to medical appointments provides emotional support and helps absorb complex medical information. Asking what kind of help they need rather than assuming shows respect for their autonomy[1].

Helping with dietary restrictions can be enormously helpful. Learning what foods to avoid, helping plan and prepare kidney-friendly, phosphorus-controlled meals, and making these dietary changes as a family rather than singling out the person with illness can ease the burden. Shopping for appropriate foods and being willing to modify family meals shows practical love and support[5].

Emotional support matters just as much as practical help. Simply being present, listening without trying to fix everything, and acknowledging the difficulty of living with chronic illness validates their experience. Encouraging them to express feelings rather than suppressing them, and seeking professional mental health support when needed, supports overall wellbeing. Maintaining normalcy and not letting the illness dominate every conversation helps preserve identity beyond being a patient[6].

Families should also take care of themselves. Caregiver burnout is real, and families need support too. Joining support groups for families of people with chronic kidney disease or parathyroid conditions, taking breaks when possible, and acknowledging the emotional toll on caregivers helps ensure families can provide sustainable support over the long term. Taking care of your own health enables you to better care for your loved one[6].

💊 Registered drugs used for this disease

List of officially registered medicines that are used in the treatment of this condition, based only on the provided sources:

  • Calcitriol – An active form of vitamin D used to help manage calcium levels and reduce parathyroid hormone production in patients with kidney disease
  • Doxercalciferol – An active vitamin D supplement used to lower elevated parathyroid hormone levels in chronic kidney disease patients
  • Paricalcitol – A vitamin D analog used to reduce parathyroid hormone levels in people with kidney disease
  • Phosphate binders – Medications (both calcium-based and non-calcium-based) that prevent phosphorus absorption from food in the digestive system
  • Calcimimetics (e.g., Sensipar/Cinacalcet) – Drugs that reduce parathyroid hormone production by making parathyroid cells more sensitive to calcium signals, lowering PTH levels by approximately 50% on average
  • Extended Release Calcifediol – An FDA-approved treatment for secondary hyperparathyroidism in adults with stage 3 or 4 chronic kidney disease and low vitamin D levels

Ongoing Clinical Trials on Hyperparathyroidism secondary

  • Phase 3 Evaluation of Etelcalcetide for Secondary Hyperparathyroidism in Pediatric Patients with Chronic Kidney Disease on Hemodialysis

    Recruiting

    1 1 1 1
    Investigated diseases:
    Belgium Czechia Germany Greece Italy Poland +2
  • Study of alfacalcidol for treating secondary hyperparathyroidism in patients after gastric bypass surgery

    Not yet recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands
  • Study on the Effectiveness and Safety of PLS240 for Treating Secondary Hyperparathyroidism in Patients with End Stage Kidney Disease on Hemodialysis

    Not recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    Bulgaria Poland Portugal Spain

References

https://www.kidney.org/kidney-topics/secondary-hyperparathyroidism

https://www.kidneyfund.org/living-kidney-disease/health-problems-caused-kidney-disease/secondary-hyperparathyroidism-symptoms-causes-treatment

https://www.mayoclinic.org/diseases-conditions/hyperparathyroidism/symptoms-causes/syc-20356194

https://www.ncbi.nlm.nih.gov/books/NBK557822/

https://columbiasurgery.org/conditions-and-treatments/secondary-hyperparathyroidism

https://my.clevelandclinic.org/health/diseases/14454-hyperparathyroidism

https://en.wikipedia.org/wiki/Secondary_hyperparathyroidism

FAQ

What is the difference between primary and secondary hyperparathyroidism?

Primary hyperparathyroidism occurs when one or more parathyroid glands develop a growth or become enlarged on their own, producing too much hormone without an external cause. Secondary hyperparathyroidism happens when another health condition—most commonly chronic kidney disease or vitamin D deficiency—causes low calcium or high phosphate levels, forcing all four parathyroid glands to work harder and eventually become enlarged in response to this ongoing challenge.

Can secondary hyperparathyroidism be cured?

The cure depends on the underlying cause. If secondary hyperparathyroidism is caused by vitamin D deficiency, restoring vitamin D to normal levels can resolve the condition. For patients with kidney failure, a kidney transplant offers the best chance for cure, though some people continue to have elevated parathyroid hormone levels even after transplant. When medical treatment fails, surgery can remove overactive parathyroid tissue, but this doesn’t fix the underlying kidney problem, so there’s a risk of recurrence.

Why do people with kidney disease develop secondary hyperparathyroidism?

Failing kidneys can’t convert vitamin D into its active form, which means the intestines can’t absorb calcium properly from food. Additionally, diseased kidneys can’t remove phosphorus effectively, causing it to build up in the blood. Both low calcium and high phosphorus signal the parathyroid glands to produce more hormone to try to correct these imbalances. Over time, this constant stimulation causes the parathyroid glands to grow larger and produce even more hormone.

What are the warning signs that secondary hyperparathyroidism is getting worse?

Warning signs include worsening bone pain, increasing muscle weakness, severe uncontrollable itching, symptoms of calciphylaxis (painful purple skin lesions), extremely high parathyroid hormone levels that continue rising despite treatment, and inability to control calcium and phosphorus levels even with dialysis. If you experience any of these symptoms, it’s important to discuss them with your healthcare team as they may indicate the need for different or more aggressive treatment.

Do medications for secondary hyperparathyroidism work for everyone?

Unfortunately, no. While medical treatment including phosphate binders, vitamin D supplements, and calcimimetic drugs helps control the condition in many patients, studies show that up to 25% of people with kidney failure and secondary hyperparathyroidism do not respond adequately to medication alone. For these individuals, surgery may be necessary to remove some or all of the overactive parathyroid tissue.

🎯 Key takeaways

  • Secondary hyperparathyroidism is most commonly caused by chronic kidney disease, which affects about 15% of people in the United States, with prevalence increasing as kidney function declines.
  • The condition can progress to tertiary hyperparathyroidism if left untreated long-term, where the parathyroid glands become irreversibly enlarged and continue producing excess hormone even if the underlying problem is fixed.
  • Cardiovascular complications from calcium deposits in blood vessels and heart tissue are a major cause of illness and death in people with untreated secondary hyperparathyroidism.
  • Calciphylaxis, though rare, is a severe complication causing painful skin lesions that can progress to tissue death and requires emergency treatment.
  • Medical treatment doesn’t work for up to 25% of patients with kidney-related secondary hyperparathyroidism, necessitating surgical options.
  • For people whose secondary hyperparathyroidism is caused by vitamin D deficiency—affecting about 50% of the world’s population—restoring vitamin D levels can successfully treat the condition.
  • Even after kidney transplant, many people continue to experience some degree of persistent hyperparathyroidism, requiring ongoing monitoring.
  • The disease significantly impacts daily life through bone pain, severe itching, fatigue, and dietary restrictions, affecting work, social activities, and emotional wellbeing.